Correntropy-Based Spectral Characterization of Respiratory Patterns in Patients With Chronic Heart Failure

A correntropy-based technique is proposed for the characterization and classification of respiratory flow signals in chronic heart failure (CHF) patients with periodic or nonperiodic breathing (PB or nPB, respectively) and healthy subjects. The correntropy is a recently introduced, generalized corre...

Full description

Saved in:
Bibliographic Details
Published inIEEE transactions on biomedical engineering Vol. 57; no. 8; pp. 1964 - 1972
Main Authors Garde, Ainara, Sörnmo, Leif, Jané, Raimon, Giraldo, Beatriz F.
Format Journal Article Publication
LanguageEnglish
Published United States IEEE 01.08.2010
The Institute of Electrical and Electronics Engineers, Inc. (IEEE)
Subjects
Online AccessGet full text
ISSN0018-9294
1558-2531
1558-2531
DOI10.1109/TBME.2010.2044176

Cover

Loading…
More Information
Summary:A correntropy-based technique is proposed for the characterization and classification of respiratory flow signals in chronic heart failure (CHF) patients with periodic or nonperiodic breathing (PB or nPB, respectively) and healthy subjects. The correntropy is a recently introduced, generalized correlation measure whose properties lend themselves to the definition of a correntropy-based spectral density (CSD). Using this technique, both respiratory and modulation frequencies can be reliably detected at their original positions in the spectrum without prior demodulation of the flow signal. Single-parameter classification of respiratory patterns is investigated for three different parameters extracted from the respiratory and modulation frequency bands of the CSD, and one parameter defined by the correntropy mean. The results show that the ratio between the powers in the modulation and respiratory frequency bands provides the best result when classifying CHF patients with either PB or nPB, yielding an accuracy of 88.9%. The correntropy mean offers excellent performance when classifying CHF patients versus healthy subjects, yielding an accuracy of 95.2% and discriminating nPB patients from healthy subjects with an accuracy of 94.4%.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0018-9294
1558-2531
1558-2531
DOI:10.1109/TBME.2010.2044176